Glassia

alpha-1 proteinase inhibitor · Grifols Therapeutics LLC

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Glassia, covering 2014-05-29 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency [Phase 3]